Startseite/Aktien/AZN

AZN

USD

AstraZeneca PLC American Depositary Shares

$82.030+1.380 (1.711%)

Echtzeitkurs

Healthcare

Drug Manufacturers - General

Vereinigtes Königreich

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$80.650

Hoch

$82.110

Tief

$80.480

Volumen

5.34M

Unternehmensfundamentaldaten

Marktkapitalisierung

255.3B

Branche

Drug Manufacturers - General

Land

United Kingdom

Handelsstatistiken

Durchschnittliches Volumen

4.52M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $61.24Aktuell $82.030Hoch $86.57

Ähnliche Nachrichten

31. Okt. 2025 · 01:00

BusinessWire

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

29. Okt. 2025 · 22:52

CNBC

ServiceNow CEO denies AI companies are threatening enterprise software: 'They don't do what we do'

ServiceNow CEO Bill McDermott pushed back against the idea that artificial intelligence technology will make enterprise software redundant.

ServiceNow CEO denies AI companies are threatening enterprise software: 'They don't do what we do'

29. Okt. 2025 · 18:19

CNBC

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.